Moores Cancer Center

It's a straightforward, roundabout story: Impact Biomedicines acquired fedratinib from Sanofi for a minority stake in the start-up, convinced the US FDA to remove a clinical hold on the JAK2 inh

IN VITRO DIAGNOSTICS Exosome Diagnostics Inc. Series B brings in $27mm for Exosome Diagnostics Exosome Diagnostics Inc. (molecular diagnostics that detect the presence of exosomes in biofluids

IN VITRO DIAGNOSTICS Arno Therapeutics Inc. University of Minnesota Arno exclusively licenses Univ. of MN 's gene expression signature technique Arno Therapeutics Inc. (oncology) licensed exc

Pioneering biologist Craig Venter, PhD, has made a career of pursuing ambitious projects, including his private endeavor to sequence the human genome and a stab at synthetic biology that could include